Bethan Lang Selected Research

Isaacs Syndrome (Neuromyotonia)

12/2018	Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.
1/2017	Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.
9/2010	Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.
6/2006	Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations.
3/2003	Autoantibodies to ion channels at the neuromuscular junction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bethan Lang Research Topics

Disease

19	Epilepsy (Aura) 01/2021 - 06/2003
18	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 06/2018 - 06/2003
15	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 10/2006
15	Seizures (Absence Seizure) 01/2020 - 10/2006
12	Glioma (Gliomas) 01/2020 - 09/2010
9	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2019 - 05/2002
8	Brain Diseases (Brain Disorder) 09/2015 - 03/2004
7	Neoplasms (Cancer) 01/2020 - 01/2011
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 03/2003
6	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 03/2003
5	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021 - 03/2011
5	Central Nervous System Diseases (CNS Diseases) 07/2019 - 05/2003
5	Isaacs Syndrome (Neuromyotonia) 12/2018 - 03/2003
5	Myasthenia Gravis 01/2018 - 03/2003
5	Stiff-Person Syndrome (Stiff Man Syndrome) 10/2016 - 06/2003
4	Autoimmune Diseases of the Nervous System 01/2021 - 03/2014
4	Partial Epilepsies (Epilepsy, Partial) 01/2021 - 06/2013
4	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2015
4	Paraneoplastic Cerebellar Degeneration 01/2019 - 08/2003
4	Inflammation (Inflammations) 06/2018 - 06/2013
4	Cognitive Dysfunction 01/2018 - 05/2011
3	Neuroblastoma 11/2021 - 01/2018
3	Thymoma (Thymic Carcinoma) 12/2018 - 03/2003
3	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 01/2017
3	Temporal Lobe Epilepsy 03/2014 - 06/2010
3	Myoclonus (Nocturnal Myoclonus) 01/2014 - 03/2011
3	Ataxia (Dyssynergia) 04/2012 - 06/2003
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 04/2010
2	Pain (Aches) 12/2018 - 01/2018
2	Schizophrenia (Dementia Praecox) 01/2017 - 04/2011
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2016 - 01/2016
2	Guillain-Barre Syndrome 09/2015 - 06/2009
2	Infections 04/2015 - 01/2005
2	Progressive Encephalomyelitis with Rigidity 01/2014 - 08/2012
2	Disease Progression 01/2013 - 08/2012
2	Ocular Motility Disorders (Convergence Insufficiency) 08/2012 - 03/2011
2	Hyponatremia 08/2012 - 05/2011
2	Cerebellar Ataxia (Dysmetria) 04/2012 - 02/2008
2	Muscle Weakness 12/2011 - 05/2002
2	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2009 - 11/2007
2	Channelopathies 01/2009 - 10/2006
1	Orthostatic Intolerance 01/2021
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2021
1	Sclerosis 06/2018
1	Necrosis 06/2018
1	Autism Spectrum Disorder 01/2018
1	Neuralgia (Stump Neuralgia) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Merkel Cell Carcinoma 11/2017
1	Neurodevelopmental Disorders 10/2017
1	Immune System Diseases (Immune Disorders) 01/2017

Drug/Important Bio-Agent (IBA)

62	AntibodiesIBA 11/2021 - 03/2003
32	AutoantibodiesIBA 01/2021 - 05/2002
20	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2003
19	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2018 - 03/2004
14	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 11/2009
12	Calcium Channels (Calcium Channel)IBA 11/2017 - 05/2002
11	Leucine (L-Leucine)FDA Link 01/2020 - 09/2010
11	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 10/2016 - 10/2006
8	Ion Channels (Ion Channel)IBA 01/2011 - 05/2003
7	Cholinergic ReceptorsIBA 11/2021 - 03/2003
7	Immunoglobulin G (IgG)IBA 01/2021 - 05/2002
5	Glycine Receptors (Glycine Receptor)IBA 01/2020 - 08/2012
4	AntigensIBA 12/2018 - 03/2003
4	Glutamate Receptors (Glutamate Receptor)IBA 01/2018 - 06/2003
4	Potassium Channels (Potassium Channel)IBA 03/2016 - 06/2003
4	N-Methylaspartate (NMDA)IBA 03/2016 - 06/2010
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2015
3	Complement System Proteins (Complement)IBA 06/2018 - 05/2014
3	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2018 - 05/2011
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 05/2011
3	Membrane Proteins (Integral Membrane Proteins)IBA 06/2013 - 04/2010
2	Contactin 2IBA 12/2018 - 09/2010
2	AMPA Receptors (AMPA Receptor)IBA 03/2016 - 04/2011
2	Aminobutyrates (Aminobutyric Acid)IBA 03/2016 - 09/2010
2	Oligoclonal BandsIBA 04/2015 - 06/2010
2	Phosphotransferases (Kinase)IBA 04/2007 - 03/2003
2	PotassiumIBA 10/2006 - 03/2003
2	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 07/2005 - 08/2003
1	Conotoxins (Conotoxin)IBA 11/2021
1	monoclonal antibody ZCE 025IBA 11/2021
1	GABA Receptors (GABA Receptor)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 06/2018
1	ParaffinIBA 06/2018
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2018
1	anti-CASPR2 autoantibodyIBA 01/2018
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2018
1	SodiumIBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2016
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2016
1	leucine receptorIBA 01/2016
1	1,3-dipropyl-8-phenylxanthineIBA 01/2016
1	AcidsIBA 01/2016
1	ConvulsantsIBA 11/2015

Therapy/Procedure

14	Immunotherapy 01/2021 - 03/2004
5	Therapeutics 01/2019 - 06/2003
1	Immunomodulation 01/2021
1	Injections 11/2015